在汉族中国患者中,BDNF基因多态化和抗抑郁药反应,患者患有第一期晚期抑郁症
Han Wu1, Jiao-Jiao Zhou1, Xue-Yan Chen1
1Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, 100088 Beijing, China.
Alpha psychiatry
|May 12, 2025
概括
这项研究发现,男性性别和特定的大脑衍生神经营养因子 (BDNF) 基因变异预测了晚年抑郁症 (LLD) 的抗抑郁药反应. 具有Val/Val基因型的男性患者可能对常规抗抑郁药物有更好的反应.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学是一种遗传学.
- 精神病学是一个精神病学.
背景情况:
- 晚年抑郁症 (LLD) 在治疗反应方面提出了独特的挑战.
- 大脑衍生神经营养因子 (BDNF) 在神经元可塑性中起着至关重要的作用,并与抑郁症有关.
- 研究BDNF多态性等遗传因素可能为个性化抗抑郁药物治疗提供了洞察力.
研究的目的:
- 为了检查BDNF基因多态性和抗抑郁药治疗疗效在首次发病的LLD患者之间的关联.
- 探索血清BDNF水平,神经心理状态和治疗结果之间的关系.
- 在这个特定的患者群体中确定抗抑郁药反应的预测因子.
主要方法:
- 招募了72名第一期LLD患者,其中57人完成了为期8周的抗抑郁药治疗课程.
- 在基线和治疗后评估抑郁症严重程度 (HAMD-17) 和神经心理功能 (RBANS).
- 使用ELISA和Agena® MassARRAY测量了血清BDNF水平和基因型BDNF多态.
主要成果:
- 在治疗后观察到HAMD-17,RBANS得分和血清BDNF水平的显著改善.
- 男性性别 (OR=10.094) 和BDNF基因多态性 (OR=6.559) 被确定为治疗疗效的显著预测因素.
- 在有效和无效治疗组之间没有发现RBANS得分或血清BDNF水平的显著差异.
结论:
- 抗抑郁药治疗对LLD患者的血清BDNF水平产生影响.
- 具有Val/Val BDNF基因型的男性患者可能对常规抗抑郁药物有更好的反应.
- 研究结果表明,BDNF基因多态可能是预测LLD治疗结果的潜在生物标志物,尽管需要进行更大规模的研究.
更多相关视频
相关概念视频
Human Genetics
474
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
474
Antidepressant Drugs: MAOIs and Other Agents
165
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
165
G-protein Coupled Receptors
112.9K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
112.9K


